#United States #Wilmington #DuPont #TPE #Liveo™

DuPont Introduces Liveo™ Pharma TPE Overmolded Assemblies

DuPont, a prominent name in advanced material science, has recently announced the launch of the Liveo™ Pharma TPE Overmolded Assemblies. These innovative components are specifically engineered for ultrapure fluid transfer, catering to both pharmaceutical and biopharmaceutical applications. This development marks a significant step in improving safety and efficiency in drug delivery and biopharmaceutical processing.

Purpose of the New Assemblies

The primary goal of the Liveo™ Pharma TPE Assemblies is to provide a reliable solution that minimizes risks associated with contamination and leakage during fluid transfer. In pharmaceutical manufacturing, the integrity of liquid systems is paramount; any contamination can lead to severe consequences for product efficacy and patient safety. Therefore, DuPont's new assemblies are designed to meet these critical needs by simplifying the transfer process while ensuring enhanced purity standards.

According to Sweden Cao Yocom, who is the Program Manager for DuPont™ Liveo™ Biopharma Processing, the introduction of these customizable assemblies is a game-changer. Not only do they streamline the extractables profiles for biopharmaceutical processing customers, but they also afford them increased choices and flexibility when opting for ultrapure fluid transport solutions.

Key Features and Benefits

The DuPont™ Liveo™ Pharma TPE Overmolded Assemblies stand out with several significant features:

• - Reduction of Contamination: By minimizing potential leak points and ensuring tight seals, these assemblies reduce the risk of contamination in the transfer of sensitive biologics.
• - Lower Extractables: Engineered for minimal extractables, these assemblies enable manufacturers to have confidence in the integrity of their products, significantly reducing cleaning and validation time.
• - Enhanced Chemical Resistance: The assemblies are designed to handle a wide range of chemicals without degradation, ensuring longevity and reliability in demanding environments.
• - Improved Heat-Welding Performance: This feature simplifies assembly processes, ensuring a strong bond while reducing the overall time and labor associated with setup.

In traditional single-use systems, extensive cleaning and validation can be cumbersome and rank among the higher costs in biopharma operations. The introduction of these assemblies aims to streamline those processes, thereby reducing operational overheads and enhancing productivity.

Applications and Use Cases

The Liveo™ Pharma TPE Assemblies are versatile, making them suitable for various applications including:

• - Gene therapies that require stringent purity to ensure patient safety.
• - Critical systems such as fill-and-finish operations where leak-free connections are non-negotiable.
• - High-value applications where contamination could lead to significant financial loss and regulatory issues.

DuPont's portfolio of biopharma processing solutions is expanding, incorporating not only the new assemblies but also Liveo™ Pharma TPE Tubing and Ultra-Low Temp Tubing, firmly establishing the company as a leader in the realm of biopharmaceutical manufacturing solutions.

Commitment to Customer Satisfaction

DuPont's dedication to its customers is further strengthened with the launch of these assemblies. By positioning themselves as a one-stop-shop for high-purity TPE solutions, DuPont aims to foster long-term relationships and collaborations with their biopharmaceutical customers. Diana Salvadori, DuPont's Global Senior Product Marketing Manager, emphasizes that this new offering complements their commitment to providing cutting-edge solutions in the biopharma industry.

For those interested in exploring the full range of features and benefits associated with the Liveo™ Pharma TPE Overmolded Assemblies, detailed information is available at liveo.dupont.com.

Conclusion

The launch of Liveo™ Pharma TPE Overmolded Assemblies by DuPont marks an important innovation in the biopharmaceutical sector. With their focus on reducing contamination risk, minimizing costs, and providing customizable solutions, DuPont is set to significantly impact how ultrapure fluids are transferred in healthcare. This commitment to innovation not only enhances product safety but also supports the overall effectiveness of vital pharmaceutical processes. As the industry continues to evolve, advancements like these are crucial in ensuring patient safety and operational excellence in healthcare.